Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 2
1951 4
1952 2
1953 9
1954 8
1955 10
1956 2
1957 9
1958 15
1959 2
1963 4
1964 8
1965 48
1966 93
1967 116
1968 190
1969 210
1970 203
1971 217
1972 240
1973 304
1974 292
1975 250
1976 215
1977 209
1978 166
1979 193
1980 189
1981 182
1982 235
1983 219
1984 217
1985 235
1986 256
1987 210
1988 247
1989 285
1990 287
1991 258
1992 311
1993 305
1994 383
1995 394
1996 408
1997 452
1998 475
1999 425
2000 435
2001 525
2002 521
2003 630
2004 636
2005 726
2006 779
2007 778
2008 936
2009 972
2010 1035
2011 1043
2012 1107
2013 1292
2014 1322
2015 1330
2016 1362
2017 1479
2018 1421
2019 1417
2020 1621
2021 1445
2022 1361
2023 1163
2024 360

Text availability

Article attribute

Article type

Publication date

Search Results

31,347 results

Results by year

Filters applied: . Clear all
Page 1
Embolic Stroke of Undetermined Source: JACC Review Topic of the Week.
Ntaios G. Ntaios G. J Am Coll Cardiol. 2020 Jan 28;75(3):333-340. doi: 10.1016/j.jacc.2019.11.024. J Am Coll Cardiol. 2020. PMID: 31976872 Free article. Review.
It was hypothesized that oral anticoagulation may decrease the risk of stroke recurrence in ESUS, which was tested in 2 large randomized controlled trials: the NAVIGATE ESUS (Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolis …
It was hypothesized that oral anticoagulation may decrease the risk of stroke recurrence in ESUS, which was tested in 2 large randomized …
Cryptogenic Stroke and Patent Foramen Ovale.
Mojadidi MK, Zaman MO, Elgendy IY, Mahmoud AN, Patel NK, Agarwal N, Tobis JM, Meier B. Mojadidi MK, et al. J Am Coll Cardiol. 2018 Mar 6;71(9):1035-1043. doi: 10.1016/j.jacc.2017.12.059. J Am Coll Cardiol. 2018. PMID: 29495983 Free article. Review.
Early randomized clinical trials failed to demonstrate a significant benefit of percutaneous PFO closure for secondary prevention of cryptogenic stroke in an intention-to-treat analysis. The long-term follow-up data from the RESPECT trial and 2 new randomi …
Early randomized clinical trials failed to demonstrate a significant benefit of percutaneous PFO closure for secondary prevent …
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
Carnicelli AP, Hong H, Connolly SJ, Eikelboom J, Giugliano RP, Morrow DA, Patel MR, Wallentin L, Alexander JH, Cecilia Bahit M, Benz AP, Bohula EA, Chao TF, Dyal L, Ezekowitz M, A A Fox K, Gencer B, Halperin JL, Hijazi Z, Hohnloser SH, Hua K, Hylek E, Toda Kato E, Kuder J, Lopes RD, Mahaffey KW, Oldgren J, Piccini JP, Ruff CT, Steffel J, Wojdyla D, Granger CB; COMBINE AF (A Collaboration Between Multiple Institutions to Better Investigate Non-Vitamin K Antagonist Oral Anticoagulant Use in Atrial Fibrillation) Investigators. Carnicelli AP, et al. Circulation. 2022 Jan 25;145(4):242-255. doi: 10.1161/CIRCULATIONAHA.121.056355. Epub 2022 Jan 5. Circulation. 2022. PMID: 34985309 Free PMC article. Clinical Trial.
METHODS: We used individual patient data from the COMBINE AF (A Collaboration Between Multiple Institutions to Better Investigate Non-Vitamin K Antagonist Oral Anticoagulant Use in Atrial Fibrillation) database, which includes all patients randomized in the 4 pivotal trial …
METHODS: We used individual patient data from the COMBINE AF (A Collaboration Between Multiple Institutions to Better Investigate Non-Vitami …
VTE Prophylaxis in Critically Ill Adults: A Systematic Review and Network Meta-analysis.
Fernando SM, Tran A, Cheng W, Sadeghirad B, Arabi YM, Cook DJ, Møller MH, Mehta S, Fowler RA, Burns KEA, Wells PS, Carrier M, Crowther MA, Scales DC, English SW, Kyeremanteng K, Kanji S, Kho ME, Rochwerg B. Fernando SM, et al. Chest. 2022 Feb;161(2):418-428. doi: 10.1016/j.chest.2021.08.050. Epub 2021 Aug 19. Chest. 2022. PMID: 34419428
BACKGROUND: Critically ill adults are at increased risk of VTE, including DVT, and pulmonary embolism. Various agents exist for venous thromboprophylaxis in this population. ...STUDY DESIGN AND METHODS: Systematic review and network meta-analysis of randomized cl …
BACKGROUND: Critically ill adults are at increased risk of VTE, including DVT, and pulmonary embolism. Various agents exist for venou …
Physical activity in patients with deep venous thrombosis: a systematic review.
Kahn SR, Shrier I, Kearon C. Kahn SR, et al. Thromb Res. 2008;122(6):763-73. doi: 10.1016/j.thromres.2007.10.011. Epub 2007 Dec 21. Thromb Res. 2008. PMID: 18078981 Review.
Bibliographies of retrieved articles and personal files were also searched. REVIEW METHODS: Randomized trials and prospective cohort studies that included patients with acute or previous DVT, described an exercise intervention or exercise exposure, and described any relate …
Bibliographies of retrieved articles and personal files were also searched. REVIEW METHODS: Randomized trials and prospective cohort …
Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials.
King B, Mostaghimi A, Shimomura Y, Zlotogorski A, Choi GS, Blume-Peytavi U, Passeron T, Holzwarth K, Dutronc Y, McCollam J, Yang FE, Stanley S, Wu WS, Sinclair R. King B, et al. Br J Dermatol. 2023 Feb 10;188(2):218-227. doi: 10.1093/bjd/ljac059. Br J Dermatol. 2023. PMID: 36763878
OBJECTIVES: To report safety data for baricitinib in patients with severe AA from two clinical trials including long-term extension periods. METHODS: This analysis includes pooled patient-level safety data from two trials, an adaptive phase II/III trial (BRAVE-AA1) …
OBJECTIVES: To report safety data for baricitinib in patients with severe AA from two clinical trials including long-term extension p …
A multi-national trial of a direct oral anticoagulant in children with cardiac disease: Design and rationale of the Safety of ApiXaban On Pediatric Heart disease On the preventioN of Embolism (SAXOPHONE) study.
Payne RM, Burns KM, Glatz AC, Li D, Li X, Monagle P, Newburger JW, Swan EA, Wheaton O, Male C; Pediatric Heart Network Investigators. Payne RM, et al. Am Heart J. 2019 Nov;217:52-63. doi: 10.1016/j.ahj.2019.08.002. Epub 2019 Aug 9. Am Heart J. 2019. PMID: 31493728 Free PMC article.
This manuscript describes the design, rationale, and methods of a prospective, randomized, open label phase II multi-national clinical trial of a direct oral anticoagulant (DOAC), apixaban, in children and infants with congenital and acquired heart disease. . …
This manuscript describes the design, rationale, and methods of a prospective, randomized, open label phase II multi-national clin …
Surgery for obesity.
Colquitt JL, Picot J, Loveman E, Clegg AJ. Colquitt JL, et al. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD003641. doi: 10.1002/14651858.CD003641.pub3. Cochrane Database Syst Rev. 2009. PMID: 19370590 Updated. Review.
SEARCH STRATEGY: Studies were obtained from computerized searches of multiple electronic bibliographic databases, supplemented with searches of reference lists and consultation with experts in obesity research. SELECTION CRITERIA: Randomised controlled trials (RCTs) compar …
SEARCH STRATEGY: Studies were obtained from computerized searches of multiple electronic bibliographic databases, supplemented with searches …
Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period.
Middleton P, Shepherd E, Gomersall JC. Middleton P, et al. Cochrane Database Syst Rev. 2021 Mar 29;3(3):CD001689. doi: 10.1002/14651858.CD001689.pub4. Cochrane Database Syst Rev. 2021. PMID: 33779986 Free PMC article.
In addition, we searched ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform (ICTRP) for unpublished, planned and ongoing trial reports (18 October 2019). ...Peripartum/postnatal prophylaxis Vaginal or caesarean birth When UFH and no treat …
In addition, we searched ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform (ICTRP) for unpublished, plan …
PREVENTion of CLots in Orthopaedic Trauma (PREVENT CLOT): a randomised pragmatic trial protocol comparing aspirin versus low-molecular-weight heparin for blood clot prevention in orthopaedic trauma patients.
O'Toole RV, Stein DM, Frey KP, O'Hara NN, Scharfstein DO, Slobogean GP, Taylor TJ, Haac BE, Carlini AR, Manson TT, Sudini K, Mullins CD, Wegener ST, Firoozabadi R, Haut ER, Bosse MJ, Seymour RB, Holden MB, Gitajn IL, Goldhaber SZ, Eastman AL, Jurkovich GJ, Vallier HA, Gary JL, Kleweno CP, Cuschieri J, Marvel D, Castillo RC; METRC. O'Toole RV, et al. BMJ Open. 2021 Mar 24;11(3):e041845. doi: 10.1136/bmjopen-2020-041845. BMJ Open. 2021. PMID: 33762229 Free PMC article.
Recruitment began in April 2017 and will continue through 2021. As both study medications are currently in clinical use for VTE prophylaxis for orthopaedic trauma patients, the findings of this trial can be easily adopted into clinical practice. ...TRIAL …
Recruitment began in April 2017 and will continue through 2021. As both study medications are currently in clinical use for VTE proph …
31,347 results
You have reached the last available page of results. Please see the User Guide for more information.